Examination of electrocardiogram QT intervals prolongation after taking Escitalopram
Not Applicable
- Conditions
- Major Depressive Disorder
- Registration Number
- JPRN-UMIN000014832
- Lead Sponsor
- St. Marianna University School Of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) The patient with a history of hypersensitivity for the ingredient of the study drug 2) The patient who is taking a monoamine oxidase (MAO) inhibitor or the patient who stops taking the drug within 14 days 3) The patient who is taking Pimozide 4) The patient who has QT interval over 500 msec 5) The patient who has long QT syndrome and arrhythmia to need treatment or the heart disorder (coronary artery disease, myocardial desease, valve disorder and heart failure) 6) The patient who is regarded as the inappropriate person by a doctor who is in charge of the examination
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Confirmation of the QT prolonged with taking Escitalopram
- Secondary Outcome Measures
Name Time Method 1)Correlation of the QT intervals measured by 12 instruction and mobile electrocardiograph 2)Prevalence of the QT value over 500msec 3)Observation of the QT value area according to the subjects background factor